Recap Two weeks ago, we looked at the candlestick that formed on the daily chart in GC, which eventually closed as a spinning top at the top of an up trend. It signals to us that there is much confusion in the market when a candlestick like this forms, and this gave us a short Read More…
Gold prices fell on Thursday as investors preferred the dollar as a haven amid downbeat US economic data. Even though gold is considered a hedge against inflation and uncertainty, high-interest rates diminish the appeal of the non-yielding asset. Last week, there was a notable spike in the number of unemployed Americans filing new claims for Read More…
On Wednesday, oil prices fell by more than a dollar a barrel, ending a three-day rally. The drop came after economic data suggested that the US Federal Reserve may hike interest rates further. US consumer prices rose in April, potentially increasing the likelihood of higher interest rates. Global interest rate increases have worried traders about Read More…
US equities dipped on Tuesday as investors exercised increased caution in anticipation of the US consumer price index report. Investors were also awaiting a meeting between US political leaders to discuss the debt ceiling. The Labor Department’s consumer price index (CPI) report will come out on Wednesday, and investors will closely analyze it for any Read More…
Technical analysis RSI: The rsi is the indicator showing bearish divergence in the daily chart. Looking at the chart below, the divergence is strong, and this tells us that we shouldn’t consider taking long positions. Squeeze: The price action has been squeezing toward the top of the recent move. This indicates less buying pressure is present, and Read More…
The US equities rally paused on Monday as investors shifted their focus to a key inflation reading later in the week. Throughout the day, stocks struggled for direction due to disappointing earnings from Tyson Foods and Catalent and a short-lived rebound in regional banks. Catalent Inc’s shares tumbled as the contract drug manufacturer reported lower Read More…
